Tag Archives: pharmacare

Interview with , professor of health policy at the University of British Columbia School of Population and Public Health and , physician at St. Michael’s Hospital in Toronto and assistant professor in the Department of Family and Community Medicine at the University of Toronto.

Dr. Morgan, Dr. Persaud and their co-authors published a in CMAJ in which they estimated the likely savings from public coverage of a list of essential medicines across Canada. They explain their findings in this podcast.

Listen to the author interview:

...continue reading

Medical Students, (Dalhousie University), Jackie Vanek (University of Ottawa), (Queen’s University) and (University of Manitoba), are the team responsible for

 

 

TEN. This is the percentage of Canadians who are .

NINETY-ONE. This is the   in favour of a Universal Pharmacare strategy for Canada.

SEVEN BILLION. This is the amount of Canadian dollars that on prescription drug expenditures every year.

The statistics speak for themselves. The evidence, published in countless editorials and reports across the country, is difficult to deny.

On average, on prescription drug coverage. Of these nations, Canada has the fastest rising drug costs. These costs are often shouldered by our patients due to the low proportion of public funding for pharmaceutical products. Our current system is fragmented and inefficient, leading to profound inequities with regards to who gets to fill their medication prescriptions and thus, who gets to access our health care system. ...continue reading

CMAJ deputy editors Dr. Matthew Stanbrook and Dr. Kirsten Patrick discuss an written by Dr. Stanbrook. Too often, at election time, Canadians ignore pressing health care concerns and let economic fears dominate how we vote. This needs to change. A plan for strong federal leadership in health should be front and centre in this year’s election.

Also, a research article by McAlister et. al., , looks at level of physician experience and its effect on important patient outcomes that proxy for quality of care. Physician groups were stratified according to years since graduation. Dr. Matthew Stanbrook, deputy editor, provides an editor's summary of the article and its findings.

-----------------------------------

Subscribe to CMAJ Podcasts on , , Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our. Our podcasts are also released on  and here on the blogs.

Highlights from the , presented by Dr. Diane Kelsall, deputy editor.

  • Persistence of meningococcal immunity
  • Heart failure and ejection fraction
  • Pitted keratolysis
  • Canada can afford universal pharmacare
  • Failure to address at-risk drinking
  • Drinking water advisories

...continue reading

Dr. Matthew Stanbrook, deputy editor of CMAJ, interviews , family physician and VP of Medical Affairs and Health System Solutions at Women's College Hospital in Toronto (and she made headlines last year when she eloquently in front of the US Senate during the Obamacare debate).

Dr. Martin and co-authors (, , , ) say that implementing universal public coverage of prescription drugs in Canada would be estimated to reduce total spending by $7.2 billion while increasing government costs by only $1.0 billion. This economic modeling study shows that universal public drug coverage could be implemented without substantially increasing government spending.

-----------------------------------

Subscribe to CMAJ Podcasts on , , Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our. Our podcasts are also released on and here on the blogs.